Learn More
Medchemexpress LLC Neratinib (maleate) | 915942-22-2 | 99.7% | 673.11 | 1 ML

Supplier: Medchemexpress LLC HY32721B10MM/1ML
Neratinib (HKI-272) maleate is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively. This product is for research use only.
- Inhibits HER2 and EGFR with IC50s of 59 nM and 92 nM.
- Shows anticancer activities against cancer cells expressing high levels of HER-2 or EGFR.
- Reduces tumor growth in a dose-dependent manner in various xenografts.
- Inhibits proliferation of cell lines with high HER-2 levels.
- Arrests cell cycle at G1-S phase in BT474 cells.
- Inhibits MAPK and Akt phosphorylation.
- Down-regulates cyclin D1 levels and induces p27.
- Inactive in MX-1 and MCF-7 xenografts.
- Inhibited phosphorylation of HER-2 in BT474 xenografts.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.